Abstract Idiopathic CD4 lymphocytopenia is a very rare condition resulting in an immunodeficiency disorder that may or may not result in opportunistic infections. Since its description in the early 1990s, the reason for this immune deficiency has remained unclear. Its association with viral illnesses, such as West Nile virus infection, has yet to be described. We report a 26-year-old patient who presented with fever, ascending paralysis, and progressive weakness of the upper extremities. To our knowledge, this is the first case of neuroinvasive West Nile virus occurring in the context of a diagnosis of idiopathic CD4 lymphocytopenia.
Introduction
Idiopathic CD4 lymphocytopenia (ICL) may be asymptomatic and diagnosed incidentally or may present with a variety of opportunistic infections, including some neurologic and autoimmune disorders [1] [2] [3] . Likewise, West Nile virus (WNV) may be asymptomatic, present with a mild febrile illness, or present in a neuroinvasive form with encephalitis, meningitis, and/or paralysis [4] .
incontinence. The patient stated that her symptoms began in March. She lived in the desert climate of southwest New Mexico, and there were several cases of WNV infection reported in that time period and location. She did not recall receiving a mosquito bite but frequently spent time in the yard. Her medical history included generalized malaise, gastroenteritis-type symptoms, and intermittent frontal headache with a vesicular rash over her lower back that was treated with valacyclovir.
On admission, her temperature was 103 • F, her blood pressure (BP) was 110/78 mmHg, and her pulse was 102 beats/min.
A physical examination was unremarkable except for grade 2/5 strength in the lower extremities, which progressed to 0/5 strength over the first 48 h of her admission; deep tendon reflexes were absent. Sensation was mildly impaired. Her upper extremity strength was 4/5 bilaterally with normal sensation.
On admission, labs showed the following: white blood cell count, 5700 cells/mm 3 ; hemoglobin, 11 g/dL; hematocrit, 34%; and platelet count, 212,000 cells/mm 3 She was started empirically on plasmapheresis and high-dose intravenous steroid therapy with a presumptive diagnosis of a Guillain-Barre syndrome-like presentation versus transverse myelitis. She was also started on IV valacyclovir until the CSF HSV PCR results were available. When the results were reported as negative, the valacyclovir was discontinued. The rash resolved on its own.
Despite the plasmapheresis, steroids, and intravenous valacyclovir, she made very little progress in terms of improvement in strength. The use of IV immunoglobulin was not deemed useful in this situation and was therefore not used. The repeat CD4 count performed 7 weeks after admission was 98 cells/mm 3 . Serum WNV IgG remained elevated by EIA (LabCorp, Dallas, TX).
Based on these findings, a presumptive diagnosis was made of ICL complicated by neuroinvasive WNV disease.
Discussion
ICL was first described in 1992 by the Centers for Disease Control and Prevention (CDC) as a depletion of CD4 T-lymphocytes (absolute count <300/L or <20% of total lymphocytes) at a minimum of two separate time points at least 6 weeks apart, with no evidence of HIV infection and an absence of any defined immunodeficiency or therapy associated with reduced levels of CD4T cells [1, 7] . ICL is very rare; several studies have been performed to identify patients with ICL. One study screened 2028 blood donors and did not identify a single case; another study of 275 blood donors, 970 transfusion recipients, and 947 household contacts of transfusion recipients identified 12 cases (0.5%). The prevalence of ICL is generally accepted to be <1%, although the true prevalence may be slightly higher than the reported number, as the condition can be asymptomatic [1] .
The depletion of CD4 T-lymphocytes in ICL may go unnoticed, but ICL patients are predisposed to a variety of diseases due to their immunodeficiency. The clinical picture of ICL regarding opportunistic infections closely parallels HIV due to the similar nature of the diseases. Common infections associated with ICL include cryptococcosis, toxoplasmosis, histoplasmosis, and non-tuberculosis mycobacterial infections [6, 8] . Other associated infections include herpes zoster (as observed in our patient), Kaposi's sarcoma, human papillomavirus, Epstein-Barr virus, cytomegalovirus, and candidiasis [1, 3, 7] . Many cases of progressive multifocal leukoencephalopathy have also been reported in association with ICL [2,9,10] in addition to an increased incidence of autoimmune diseases [3, 6] ( Table 1) . Treatment for ICL varies depending on the presentation. Patients presenting with opportunistic infections should undergo therapy for the specific condition with which they present. Asymptomatic cases that are discovered incidentally should be monitored regularly to evaluate CD4 lymphocyte counts and to watch for the development of opportunistic infections, which are most likely to develop in the first few months after the initial presentation. Experimental cytokine therapy, such as synthetic IL-2 and IL-7 treatments, has had a varying degree of success in increasing CD4 lymphocyte counts, although specific therapy is difficult due to the unclear mechanism of ICL [3] . A handful of cases have reportedly been treated with allopathic bone marrow transplantation, also with varying success [13] . Several studies have reported the recovery of CD4 lymphocyte counts to normal limits, whereas other studies have not shown significant effects. There are a very small number of reported attempts to treat ICL with bone marrow transplantation, which is generally used as a last resort for extreme cases; its clinical utility is not yet established [13] . We were unable to confirm whether ICL preceded WNV infection in our patient or began afterward.
WNV was first reported in New York in 1999. More recently, Texas was the primary site of an outbreak of the disease in 2012 [11] . According to data gathered by the CDC in 2011, the median age of WNV patients was 57 years (range 7-96 years), and 60% of patients were male. Moreover, 93% of the cases in that year occurred between July and September, with a peak onset in late August.
In our patient's hometown in the southwestern USA, we have observed several cases of documented WNV disease with a variety of presentations ranging from asymptomatic to simple headaches to flaccid paralysis. The method used here to make the diagnosis included the clinical presentation, the current epidemiology, and EIA for serological and CSF analyses.
According to the reference laboratory (LabCorp, Dallas), the EIA test is 95% accurate when one considers the clinical presentation and the concurrent epidemiology and season in which the case presented. The case would have been more convincing if we had been able to obtain WNV CSF PCR results, but this information was not available to us.
The CDC reported 712 cases of WNV in 2011. Of those 712 cases, 486 (68%) were neuroinvasive; of those 486 cases, 30 (6%) had acute flaccid paralysis. Some cases of paralysis did not develop until 3-7 months after WNV infection [5] , which is consistent with the presentation of our patient, although the onset of paralysis can also occur within hours of presentation in some cases [12] . WNV infection may present with concurrent autoimmune disorders, and the possible delayed onset of paralysis following initial infection may be due to an immune-mediated neuropathic process [4] . Our patient appears to follow the pattern described in the literature with delayed paralysis and with ICL being the predisposing cause for the infection (Table 2) .
Neuroinvasive WNV with a background of immunodeficiency is very uncommon. According to a report from April 2013, there have been five reported cases of neuroinvasive WNV disease in HIVinfected patients in the USA. Of these five patients, two recovered with complete resolution of their symptoms, and one patient's disease was complicated by pneumonia that progressed to respiratory failure and subsequent death; the outcomes of the final two patients were unknown [11] . No record of neuroinvasive WNV with a background of ICL was identified. Our patient's neuroinvasive WNV disease appears to have been precipitated by the immunodeficiency (although we cannot be absolutely sure of this possibility) or might have been an unusual presentation of both diseases occurring simultaneously [5, 6] .
In summary, our case demonstrates a possible presentation of ICL concurrent with neuroinvasive WNV infection when considering the clinical presentation, the season in which it occurred, and serological findings. This case demonstrates several interesting points. 
